[DOI] [PubMed] [Google Scholar] 74.Perna S., Guido D., Bologna C., Solerte S.B., Guerriero F., Isu A., Rondanelli M
Exploring Next-Generation GLP-1 Multi-Agonists The science behind GLP-1s is advancing quickly, and researchers are already developing next-generation therapies called multi-agonists
Peptides are one part of a multi-phase plan, not a standalone fix
NOTCH1/HES1 upregulation in GSCs drives invasion and recurrence [32]
Except as otherwise provided herein, you may not use, download, upload, copy, print, display, perform, reproduce, publish, modify, delete, add to, license, post, transmit, or distribute any such materials from CaliforniaPetPharmacy.com in whole or in part, for any public or commercial purpose without our specific written permission
2019;186:838 Lin S, Zhou Z, Xu C, Zeng F, Shi Z, Sun J, et al